Molecular farming on rescue of pharma industry for next generations

Critical Reviews in Biotechnology

Volumn 36, Issue 5, 2016, Pages 840-850

  Moustafa, Khaled ^a   Makhzoum, Abdullah ^b   Trémouillaux Guiller, Jocelyne ^c  

^a University of Paris Cité   (France)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Molecular farming; molecular farming applications; molecular pharming; plant made pharmaceuticals; plant molecular farming; protein stability; recombinant proteins; therapeutic drug

Indexed keywords

ACCIDENT PREVENTION; NUCLEIC ACIDS; PLANTS (BOTANY); PROTEINS;

MOLECULAR FARMING; MOLECULAR PHARMING; PLANT-MADE PHARMACEUTICALS; PROTEIN STABILITY; THERAPEUTIC DRUGS;

RECOMBINANT PROTEINS;

GLYCOPROTEIN; RECOMBINANT PROTEIN;

BIOENGINEERING; BIOTECHNOLOGY; CELL SUSPENSION; CELLULAR DISTRIBUTION; CROP; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; HAIR ROOT; IMMUNOGENICITY; LEMNA; MICROALGA; MOLECULAR FARMING; MOSS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STABILITY; REVIEW; RISK REDUCTION; TRANSGENE; ANIMAL; BIOSYNTHESIS; DRUG INDUSTRY; GLYCOSYLATION; HUMAN; METABOLISM; TRANSGENIC PLANT;

ANIMALS; DRUG INDUSTRY; GLYCOSYLATION; HUMANS; MOLECULAR FARMING; PLANTS, GENETICALLY MODIFIED; PROTEIN STABILITY; RECOMBINANT PROTEINS;

EID: 84978708782     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.3109/07388551.2015.1049934     Document Type: Review

References (114)

1. A.Alderborn, J.Sundstrom, D.Soeria-Atmadja,. (2010). Genetically modified plants for non-food or non-feed purposes: straightforward screening for their appearance in food and feed. Food Chem Toxicol, 48, 453–64
2. E.Andrianantoandro. (2014). Next-generation therapeutics. Trends Biotechnol, 32, 431–2
3. R.Apweiler, H.Hermjakob, N.Sharon. (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta, 1473, 4–8
4. M.Bardor, C.Loutelier-Bourhis, T.Paccalet,. (2003). Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol J, 1, 451–62
5. A.Barta, K.Sommergruber, D.Thompson,. (1986). The expression of a nopaline synthase – human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol, 6, 347–57
6. P.Basaran, E.Rodriguez-Cerezo. (2008). Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol, 28(3), 153–72
7. B.M.Bishop. (2015). Potential and emerging treatment options for ebola virus disease. Ann Pharmacother, 49, 196–206
8. S.Boivin, S.Kozak, R.Meijers. (2013). Optimization of protein purification and characterization using Thermofluor screens. Protein Expr Purif, 91, 192–206
9. J.Boothe, C.Nykiforuk, Y.Shen. (2010). Seed-based expression systems for plant molecular farming. Plant Biotechnol J, 8, 588–606
10. D.Boyhan, H.Daniell. (2011). Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol J, 9, 585–98
11. J.F.Buyel, J.A.Bautista, R.Fischer, V.M.Yusibov. (2012). Extraction, purification and characterization of the plant-produced HPV16 subunit vaccine candidate E7 GGG. J Chromatogr B, 880, 19–26
12. B.Byrne, G.G.Donohoe, R.O'Kennedy. (2007). Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today, 12, 319–26
13. C.Capodicasa, P.Chiani, C.Bromuro,. (2011). Plant production of anti-beta-glucan antibodies for immunotherapy of fungal infections in humans. Plant Biotechnol J, 9, 776–87
14. A.Castilho, R.Strasser, J.Stadlmann,. (2010). In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem, 285, 15923–30
15. Q.Chen, H.Lai, J.Hurtado,. (2013). Agroinfiltration as an effective and scalable strategy of gene delivery for production of pharmaceutical proteins. Adv Tech Biol Med, 1, 103
16. S.C.Cheung, L.Z.Liu, L.L.Lan,. (2011). Glucose lowering effect of transgenic human insulin-like growth factor-I from rice, in vitro and in vivo studies. BMC Biotechnol, 11, 37
17. J.L.Clarke, H.Daniell, J.M.Nugent. (2011). Chloroplast biotechnology, genomics and evolution: current status, challenges and future directions. Plant Mol Biol, 76, 207–9
18. G.Corrado, M.Karali. (2009). Inducible gene expression systems and plant biotechnology. Biotechnol Adv, 27, 733–43
19. N.B.Cunha, A.M.Murad, G.L.Ramos,. (2011). Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res, 20, 841–55
20. M.A.D'Aoust, M.M.Couture, N.Charland,. (2010). The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J, 8, 607–19
21. B.De Muynck, C.Navarre, Y.Nizet,. (2009). Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res, 18, 467–82
22. E.L.Decker, R.Reski. (2007). Moss bioreactors producing improved biopharmaceuticals. Curr Opin Biotechnol, 18, 393–8
23. P.M.Doran. (2006). Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol, 24, 426–32
24. M.J.Dus Santos, A.Wigdorovitz. (2005). Transgenic plants for the production of veterinary vaccines. Immunol Cell Biol, 83, 229–38
25. L.S.Erlendsson, M.O.Muench, U.Hellman,. (2010). Barley as a green factory for the production of functional Flt3 ligand. Biotechnol J, 5, 163–71
26. L.Faye, A.Boulaflous, M.Benchabane,. (2005). Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine, 23, 1770–8
27. L.Faye, V.Gomord. (2010). Success stories in molecular farming-a brief overview. Plant Biotechnol J, 8, 525–8
28. R.Fischer, S.Schillberg, S.Hellwig,. (2012). GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv, 30, 434–9
29. D.M.Floss, M.Sack, E.Arcalis,. (2009). Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J, 7, 899–913
30. B.A.Fong, W.Y.Wu, D.W.Wood. (2009). Optimization of ELP-intein mediated protein purification by salt substitution. Protein Expr Purif, 66, 198–202
31. A.D.Frey, S.R.Karg, P.T.Kallio. (2009). Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol J, 7, 33–48
32. N.Fukuzawa, T.Ishihara, N.Itchoda,. (2011). Risk-managed production of bioactive recombinant proteins using a novel plant virus vector with a helper plant to complement viral systemic movement. Plant Biotechnol J, 9, 38–49
33. X.Ge, K.Trabbic-Carlson, A.Chilkoti, C.D.Filipe. (2006). Purification of an elastin-like fusion protein by microfiltration. Biotechnol Bioeng, 95, 424–32
34. D.Ghaderi, M.Zhang, N.Hurtado-Ziola, A.Varki. (2012). Production platforms for biotherapeutic glycoproteins: occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev, 28, 147–75
35. Y.Gleba, V.Klimyuk, S.Marillonnet. (2005). Magnifection – a new platform for expressing recombinant vaccines in plants. Vaccine, 23, 2042–8
36. V.Gomord, A.C.Fitchette, L.Menu-Bouaouiche,. (2010). Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J, 8, 564–87
37. D.O.Govea-Alonso, N.Rubio-Infante, A.L.Garcia-Hernandez,. (2013). Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta, 4, 785--92
38. R.Greco, M.Michel, D.Guetard,. (2007). Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine, 25, 8228–40
39. J.A.Gregory, S.P.Mayfield. (2014). Developing inexpensive malaria vaccines from plants and algae. Appl Microbiol Biotechnol, 5, 1983--90
40. S.Guillon, J.Tremouillaux-Guiller, P.K.Pati,. (2006). Hairy root research: recent scenario and exciting prospects – commentary. Curr Opin Plant Biol, 9, 341–6
41. G.Guzman, A.Walmsley, D.Webster, J.Hamill. (2011). Hairy roots cultures from different Solanaceous species have varying capacities to produce E. coli B-subunit heat-labile toxin antigen. Biotechnol Lett, 33, 2495–502
42. X.He, J.D.Galpin, M.B.Tropak,. (2012). Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants. Glycobiology, 22, 492–503
43. K.Hefferon. (2014). Plant virus expression vector development: new perspectives. Biomed Res Into, 2014, 785382
44. C.Hernandez-Garcia, A.Martinelli, R.Bouchard, J.Finer. (2009). A soybean (Glycine max) polyubiquitin promoter gives strong constitutive expression in transgenic soybean. Plant Cell Rep, 28, 837–49
45. L.C.Hudson, R.Garg, K.L.Bost, K.J.Piller. (2014). Soybean seeds: a practical host for the production of functional subunit vaccines. Biomed Res Int, 2014, 340804
46. N.X.Huy, M.S.Yang, T.G.Kim. (2011). Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.). Mol Biotechnol, 48, 201–9
47. C.Jin, F.Altmann, R.Strasser,. (2008). A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology, 18, 235–41
48. J.J.Joensuu, A.J.Conley, M.B.Linder, R.Menassa. (2012). Bioseparation of recombinant proteins from plant extract with hydrophobin fusion technology. Methods Mol Biol, 824, 527–34
49. J.Kaiser. (2008). Is the drought over for pharming? Science, 320, 473–5
50. N.-S.Kim, T.-G.Kim, O.-H.Kim,. (2008a). Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture. Plant Mol Biol, 68, 263–75
51. T.-G.Kim, H.-J.Lee, Y.-S.Jang,. (2008b). Co-expression of proteinase inhibitor enhances recombinant human granulocyte–macrophage colony stimulating factor production in transgenic rice cell suspension culture. Protein Expr Purif, 61, 117–21
52. A.Koprivova, C.Stemmer, F.Altmann,. (2004). Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J, 2, 517–23
53. M.Laguia-Becher, V.Martin, M.Kraemer,. (2010). Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol, 10, 52
54. O.S.Lau, D.W.Ng, W.W.Chan,. (2010). Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J, 8, 994–1004
55. W.Li, L.Li, K.Li,. (2011). Expression of biologically active human insulin-like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology. Biotechnol Appl Biochem, 58, 139–46
56. C.Lico, L.Santi, R.M.Twyman,. (2012). The use of plants for the production of therapeutic human peptides. Plant Cell Rep, 31, 439–51
57. I.Llop-Tous, M.Ortiz, M.Torrent, M.D.Ludevid. (2011). The expression of a xylanase targeted to ER-protein bodies provides a simple strategy to produce active insoluble enzyme polymers in tobacco plants. PLoS One, 6, e19474
58. Y.Luchakivskaya, O.Kishchenko, I.Gerasymenko,. (2011). High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants. Plant Cell Rep, 30, 407–15
59. J.K.Ma, E.Barros, R.Bock,., C. European Union Framework 6 Pharma-Planta (2005). Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep, 6, 593–9
60. J.K.Ma, P.M.Drake, P.Christou. (2003). The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet, 4, 794–805
61. S.Ma, A.M.Jevnikar, N.P.A.Hüner. (2011). Microalgae as bioreactors for production of pharmaceutical proteins. Comprehens Biotechnol Second Ed, 4, 301–7
62. S.P.Mayfield, S.E.Franklin, R.A.Lerner. (2003). Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA, 100, 438–42
63. D.E.Meyer, A.Chilkoti. (1999). Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotechnol, 17, 1112–15
64. S.Naqvi, K.Ramessar, G.Farre,. (2011). High-value products from transgenic maize. Biotechnol Adv, 29, 40–53
65. L.Nopo, B.J.Woffenden, D.G.Reed,. (2012). Super-promoter: TEV, a powerful gene expression system for tobacco hairy roots. Methods Mol Biol, 824, 501–26
66. O.O.Obembe, J.O.Popoola, S.Leelavathi, S.V.Reddy. (2011). Advances in plant molecular farming. Biotechnol Adv, 29, 210–22
67. M.Oey, M.Lohse, B.Kreikemeyer, R.Bock. (2009). Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J, 57, 436–45
68. S.Ortigosa, A.Fernández-San Millán, J.Veramendi. (2010). Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain. Transgenic Res, 19, 703–9
69. M.Paul. (2015). International Society for Plant Molecular Farming: 1st Conference, Berlin-Dahlem, Germany, 17th–19th June 2014. Transgenic Res
70. M.Paul, J.K.Ma. (2011). Plant-made pharmaceuticals: leading products and production platforms. Biotechnol Appl Biochem, 58, 58–67
71. H.T.Phan, U.Conrad. (2011). Membrane-based inverse transition cycling, an improved means for purifying plant-derived recombinant protein-elastin-like polypeptide fusions. Int J Mol Sci, 12, 2808–21
72. P.Pillay, U.Schluter, S.van Wyk,. (2014). Proteolysis of recombinant proteins in bioengineered plant cells. Bioengineered, 5, 15–20
73. M.Pujol, J.Gavilondo, M.Ayala,. (2007). Fighting cancer with plant-expressed pharmaceuticals. Trends Biotechnol, 25, 455–9
74. T.Rademacher, M.Sack, E.Arcalis,. (2008). Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J, 6, 189–201
75. K.Ramessar, M.Sabalza, T.Capell, P.Christou. (2008). Maize plants: an ideal production platform for effective and safe molecular pharming. Plant Sci, 174, 409–19
76. B.A.Rasala, M.Muto, P.A.Lee,. (2010). Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J, 8, 719–33
77. S.Robert, M.Khalf, M.C.Goulet,. (2013). Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana. PLoS One, 8, e70203
78. S.Rosales-Mendoza, N.Rubio-Infante, S.Zarazua,. (2014). Plant-based vaccines for Alzheimer's disease: an overview. Expert Rev Vaccines, 13, 429–41
79. S.Rosales-Mendoza, R.E.Soria-Guerra, L.Moreno-Fierros,. (2010). Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta, 232, 409–16
80. T.Ruhlman, R.Ahangari, A.Devine,. (2007). Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J, 5, 495–510
81. E.P.Rybicki. (2014). Plant-based vaccines against viruses. Virol J, 11, 205
82. M.Sabalza, L.Madeira, C.van Dolleweerd,. (2012). Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds. Plant Mol Biol, 80(4–5), 477–88
83. M.Sabalza, E.Vamvaka, P.Christou, T.Capell. (2013). Seeds as a production system for molecular pharming applications: status and prospects. Curr Pharm Des, 19, 5543–52
84. C.Saint-Jore-Dupas, L.Faye, V.Gomord. (2007). From planta to pharma with glycosylation in the toolbox. Trends Biotechnol, 25, 317–23
85. A.Sarrion-Perdigones, M.Vazquez-Vilar, J.Palaci,. (2013). GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol, 162, 1618–31
86. S.Schillberg, N.Raven, R.Fischer,. (2013). Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Des, 19, 5531–42
87. S.Schillberg, R.M.Twyman, R.Fischer. (2005). Opportunities for recombinant antigen and antibody expression in transgenic plants – technology assessment. Vaccine, 23, 1764–9
88. A.K.Sharma, M.K.Sharma. (2009). Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv, 27, 811–32
89. P.R.Shewry, N.G.Halford. (2002). Cereal seed storage proteins: structures, properties and role in grain utilization. J Exp Bot, 53, 947–58
90. S.M.H.Shih, P.M.Doran. (2009). Foreign protein production using plant cell and organ cultures: advantages and limitations. Biotechnol Adv, 27, 1036–42
91. P.C.Sijmons, B.M.Dekker, B.Schrammeijer,. (1990). Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY), 8, 217–21
92. C.Sourrouille, E.Marquet-Blouin, M.A.D'Aoust,. (2008). Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J, 6, 702–21
93. P.A.Sparrow, R.M.Twyman. (2009). Biosafety, risk assessment and regulation of plant-made pharmaceuticals. Methods Mol Biol, 483, 341–53
94. E.Specht, S.Miyake-Stoner, S.Mayfield. (2010). Micro-algae come of age as a platform for recombinant protein production. Biotechnol Lett, 32, 1373–83
95. J.M.Staub, B.Garcia, J.Graves,. (2000). High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol, 18, 333–8
96. E.Stoger, R.Fischer, M.Moloney, J.K.Ma. (2014). Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol, 65, 743–68
97. A.M.Stomp. (2005). The duckweeds: a valuable plant for biomanufacturing. Biotechnol Annu Rev, 11, 69–99
98. S.J.Streatfield. (2007). Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J, 5, 2–15
99. Q.-Y.Sun, L.-W.Ding, G.P.Lomonossoff,. (2011). Improved expression and purification of recombinant human serum albumin from transgenic tobacco suspension culture. J Biotechnol, 155, 164–72
100. L.Tian, S.S.Sun. (2011). A cost-effective ELP-intein coupling system for recombinant protein purification from plant production platform. PLoS One, 6, e24183
101. S.Tiwari, P.C.Verma, P.K.Singh, R.Tuli. (2009). Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv, 27, 449–67
102. M.Tran, C.Van, D.J.Barrera,. (2013). Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proc Natl Acad Sci USA, 110, E15–22
103. R.Tremblay, H.Diao, N.Huner,. (2011). The development of a high-yield recombinant protein bioreactor through RNAi induced knockdown of ATP/ADP transporter in Solanum tuberosum. J Biotechnol, 156, 59–66
104. T.Tzfira, V.Citovsky. (2006). Agrobacterium-mediated genetic transformation of plants, biology and biotechnology. Curr Opin Biotechnol, 17, 147–54
105. G.R.Vianna, N.B.Cunha, A.M.Murad, E.L.Rech. (2011). Soybeans as bioreactors for biopharmaceuticals and industrial proteins. Genet Mol Res, 10, 1733–752
106. Y.Wakasa, F.Takaiwa. (2013). The use of rice seeds to produce human pharmaceuticals for oral therapy. Biotechnol J, 8, 1133–43
107. X.Wang, M.Brandsma, R.Tremblay,. (2008). A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol, 8, 87
108. S.Werner, O.Breus, Y.Symonenko,. (2011). High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proc Natl Acad Sci USA, 108, 14061–6
109. K.J.Whaley, A.Hiatt, L.Zeitlin. (2011). Emerging antibody products and Nicotiana manufacturing. Hum Vaccin, 7, 349–56
110. I.B.Wilson. (2002). Glycosylation of proteins in plants and invertebrates. Curr Opin Struct Biol, 12, 569–77
111. H.Wu, N.K.Singh, R.D.Locy,. (2004). Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana. Biotechnol Lett, 26, 787–92
112. J.Xu, M.J.Kieliszewski. (2012). A novel plant cell bioproduction platform for high-yield secretion of recombinant proteins. Methods Mol Biol, 824, 483–500
113. V.Yusibov, S.J.Streatfield, N.Kushnir,. (2013). Hybrid viral vectors for vaccine and antibody production in plants. Curr Pharm Des, 19, 5574–86
114. V.Yusibov, S.J.Streatfield, N.Kushnir. (2011). Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin, 7, 313–21